Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03391921
What this trial is testing

Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)

Who this might be right for
HPV - Anogenital Human Papilloma Virus InfectionHIV Infections
Centre Hospitalier Universitaire Saint Pierre 170
Post-approval studies (Phase 4)Study completedNCT02624349
What this trial is testing

Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

Who this might be right for
Late Complication From Kidney TransplantComplication of Transplanted LiverHuman Papillomavirus-Related Carcinoma
The Hospital for Sick Children 37
Post-approval studies (Phase 4)Study completedNCT00534638
What this trial is testing

Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 34,412
Large-scale testing (Phase 3)Study completedNCT05119855
What this trial is testing

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Who this might be right for
Papillomavirus InfectionsCoronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 165
Testing effectiveness (Phase 2)Study completedNCT04607850
What this trial is testing

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

Who this might be right for
HPV InfectionCIN1
Barinthus Biotherapeutics 108
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Large-scale testing (Phase 3)Study completedNCT02562508
What this trial is testing

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 979
Large-scale testing (Phase 3)Study completedNCT00877877
What this trial is testing

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 632
Large-scale testing (Phase 3)Study completedNCT00677677
What this trial is testing

Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients

Who this might be right for
Transplant
University of Alberta 50
Large-scale testing (Phase 3)Study completedNCT04425291
What this trial is testing

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 1,680
Large-scale testing (Phase 3)Study completedNCT03525210
What this trial is testing

Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

Who this might be right for
Human Papilloma VirusHivOrgan Transplants
Universitaire Ziekenhuizen KU Leuven 271
Large-scale testing (Phase 3)Active Not RecruitingNCT06041061
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

Who this might be right for
HPV InfectioNHPV-Related Carcinoma
Sinocelltech Ltd. 18,000
Early research (Phase 1)Study completedNCT04083196
What this trial is testing

A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Who this might be right for
HPV InfectionHPV-Related Cervical Carcinoma
National Vaccine and Serum Institute, China 90
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Large-scale testing (Phase 3)Study completedNCT00294047
What this trial is testing

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 5,752
Testing effectiveness (Phase 2)Study completedNCT00710593
What this trial is testing

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 99
Testing effectiveness (Phase 2)Study completedNCT01461993
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,499
Early research (Phase 1)Study completedNCT00667563
What this trial is testing

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Who this might be right for
Cervical CancerNonneoplastic ConditionPrecancerous Condition
AIDS Malignancy Consortium 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07824310
What this trial is testing

Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children

Who this might be right for
Human Papillomavirus (HPV) Infection
PT Bio Farma 266
Testing effectiveness (Phase 2)Study completedNCT00546078
What this trial is testing

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 116
Next Page